Nektar Therapeutics (NASDAQ:NKTR)
| 0.5269 Delayed Data As of 3:59pm ET |  +0.0019 / +0.36%Today’s Change | 0.41 Today|||52-Week Range 3.19 | -76.69% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 55.6M | 59.6M | 4.8M | 194.9M | |
| Short Term Investment Cash | 18.2M | 4.1M | -54.9M | 190.1M | ||
| Cash & Short Term Investments | 308.9M | 389.1M | 296.1M | 1.3B | ||
| Receivables | Receivables | 19.9M | 15.7M | 5.0M | 43.2M | |
| Inventories | Inventories | 11.3M | 11.1M | 10.7M | 37.8M | |
| Current Assets | Prepaid Expenses | -- | -- | 600.0K | -- | |
| Other Current Assets | 9.8M | 10.4M | 14.3M | 21.3M | ||
| Current Assets | 350.1M | 426.3M | 326.8M | 1.4B | ||
| Total Assets | Property, Plant and Equipment - Gross | 174.0M | 176.8M | 162.6M | 169.4M | |
| Depreciation | -102.7M | -111.2M | -115.1M | -120.5M | ||
| Intangible Assets | 76.5M | 76.5M | 76.5M | 76.5M | ||
| Other Assets | 80.7M | 77.0M | 77.5M | 80.7M | ||
| Total Assets | 502.1M | 568.9M | 508.9M | 2.2B | ||
| Liabilities | Accounts Payable | 2.4M | 2.8M | 4.8M | 5.9M | |
| Short Term Debt | 4.8M | 2.9M | 0.00 | 0.00 | ||
| Accrued Expenses | 12.4M | 12.7M | 19.5M | 47.6M | ||
| Other Current Liabilities | 48.1M | 48.2M | 43.1M | 66.2M | ||
| Other Liabilities | 61.2M | 72.2M | 56.2M | 82.0M | ||
| Total Liabilities | Long Term Debt | 341.6M | 331.9M | 321.0M | 308.7M | |
| Other Liabilities | 30.4M | 24.7M | 24.9M | 31.2M | ||
| Total Liabilities | 495.6M | 480.7M | 421.0M | 432.6M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 6.4M | 88.1M | 87.8M | 1.7B | ||
| Total Shareholder Equity | 6.4M | 88.1M | 87.8M | 1.7B | ||
| Share Information | Common Shares Outstanding | 135.3M | 153.2M | 159.5M | 173.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
